Literature DB >> 16864726

Percutaneous mitral annuloplasty: an anatomic study of human coronary sinus and its relation with mitral valve annulus and coronary arteries.

Daniele Maselli1, Fabio Guarracino, Francesca Chiaramonti, Federica Mangia, Gabriele Borelli, Gaetano Minzioni.   

Abstract

BACKGROUND: To allow performance of "stand-alone" mitral annuloplasty with minimal invasiveness, percutaneous techniques consisting of delivery into the coronary sinus (CS) of devices intended to shrink the mitral valve annulus have recently been tested in animal models. These techniques exploit the anatomic proximity of the CS and mitral valve annulus in ovine or dogs. Knowledge of a detailed anatomic relationship between the CS, coronary arteries, and mitral valve annulus in humans is essential to define the safety and efficacy of percutaneous techniques in clinical practice. We sought to determine the qualitative and quantitative anatomic relationships between CS and surrounding structures in human hearts. METHODS AND
RESULTS: The distance from the CS to the mitral valve annulus and the relationship between the CS and surrounding structures were studied in 61 excised cadaveric human hearts. Maximal distance from the CS to the mitral valve annulus was found to be up to 19 mm (mean, 9.7+/-3.2 mm). A diagonal or ramus branch, main circumflex artery, or its branches were located between anterior interventricular vein/CS and the mitral valve annulus in 16.4% and 63.9% of cases, respectively.
CONCLUSIONS: Surgical anatomy suggests that in humans the CS is located behind the left atrial wall at a significant distance from the mitral valve annulus. Percutaneous mitral annuloplasty devices probably shrink the mitral valve annulus only by an indirect traction mediated by the left atrial wall; a theoretical risk of compressing coronary artery branches exists. Chronic studies are needed to address this problem and to determine long-term efficacy of such methods.

Entities:  

Mesh:

Year:  2006        PMID: 16864726     DOI: 10.1161/CIRCULATIONAHA.105.609883

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  23 in total

Review 1.  Delivery of gene and cellular therapies for heart disease.

Authors:  Justin A Mariani; David M Kaye
Journal:  J Cardiovasc Transl Res       Date:  2010-05-11       Impact factor: 4.132

Review 2.  [Coronary sinus devices for treatment of functional mitral valve regurgitation. Solution or dead end?].

Authors:  H Degen; T Schneider; J Wilke; M Haude
Journal:  Herz       Date:  2013-08       Impact factor: 1.443

3.  Intervention: The AMADEUS study in perspective.

Authors:  Jason H Rogers; Steven F Bolling
Journal:  Nat Rev Cardiol       Date:  2010-01       Impact factor: 32.419

4.  Influence of left atrial and ventricular volumes on the relation between mitral valve annulus and coronary sinus.

Authors:  Antonio Sorgente; Quynh A Truong; Cristina Conca; Jagmeet P Singh; Udo Hoffmann; Francesco F Faletra; Catherine Klersy; Rinky Bhatia; Giovanni B Pedrazzini; Elena Pasotti; Tiziano Moccetti; Angelo Auricchio
Journal:  Am J Cardiol       Date:  2008-07-10       Impact factor: 2.778

Review 5.  Coronary venous system in cardiac computer tomography: Visualization, classification and role.

Authors:  Rafal Mlynarski; Agnieszka Mlynarska; Maciej Sosnowski
Journal:  World J Radiol       Date:  2014-07-28

Review 6.  Devices for mitral valve repair.

Authors:  Paolo Denti; Francesco Maisano; Ottavio Alfieri
Journal:  J Cardiovasc Transl Res       Date:  2014-01-23       Impact factor: 4.132

Review 7.  Imaging in the context of replacement heart valve development: use of the Visible Heart(®) methodologies.

Authors:  Michael G Bateman; Paul A Iaizzo
Journal:  Cardiovasc Diagn Ther       Date:  2012-09

8.  A novel approach for reducing ischemic mitral regurgitation by injection of a polymer to reverse remodel and reposition displaced papillary muscles.

Authors:  Judy Hung; Jorge Solis; J Luis Guerrero; Gavin J C Braithwaite; Orhun K Muratoglu; Miguel Chaput; Leticia Fernandez-Friera; Mark D Handschumacher; Van J Wedeen; Stuart Houser; Gus J Vlahakes; Robert A Levine
Journal:  Circulation       Date:  2008-09-30       Impact factor: 29.690

9.  Percutaneous mitral valve repair: the beginning of the end or the end of the beginning?

Authors:  Alec Vahanian; Dominique Himbert; Eric Brochet; David Messika-Zeitoun
Journal:  F1000 Med Rep       Date:  2010-03-25

Review 10.  [Percutaneous mitral valve annuloplasty with the carillon mitral contour system by cardiac dimensions. A minimally invasive therapeutic option for the treatment of severe functional mitral valve regurgitation].

Authors:  Hubertus Degen; Thomas Lickfeld; Carsten Stoepel; Michael Haude
Journal:  Herz       Date:  2009-09       Impact factor: 1.443

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.